DrugDashboards
← Home
FDA-registered establishment

Baxter R and D Europe

An establishment registered with the FDA. No drug label names this site as performing a manufacturing step; labels list it for other roles (packing, labeling, repackaging or testing), which are shown below.

Country
Belgium
Registered address
Boulevard d’ Angleterre 2-4, Braine l’ Alleud, 1420, Belgium (BEL)
Operations here
analysis
FDA identifiers
FEI 1000359047 · DUNS 400409112

FDA inspection history

Outcomes of closed FDA inspections at this site, every FDA program area; the official-action banner above considers Drug Quality Assurance inspections only.

  • VAIDrug Quality Assurance2023-02-02
  • NAIHuman Cellular, Tissue, and Gene Therapies2013-06-21
  • VAIDrug Quality Assurance2013-06-21

Drugs this plant is listed as making

0 distinct drugs across 0 products name this site for a manufacturing step (any MANUFACTURE-type role, API included); 1 more list it only for packing, labeling, repackaging or testing. Counts are per distinct generic name (case-insensitive).

No drug label names this site as a manufacturing site.

Listed for other roles only

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.